Sutro Biopharma (STRO) — Long-term Investment Intensity
Sutro Biopharma (STRO) has a Long-term Investment Intensity of 6.8% as of March 2022. Long-term investments of $20.70 Million represent 6.8% of total assets of $303.68 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Sutro Biopharma asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sutro Biopharma Long-term Investment Intensity (2019–2022)
This chart shows how Sutro Biopharma's Long-term Investment Intensity has evolved across 3 annual periods from 2019 to 2022. As of March 2022, the intensity stands at 6.8%, reflecting long-term investments of $20.70 Million against total assets of $303.68 Million USD. For the complete balance sheet picture, see Sutro Biopharma (STRO) total assets.
Annual Long-term Investment Intensity for Sutro Biopharma (2019–2022)
The table below presents the year-by-year Long-term Investment Intensity for Sutro Biopharma from 2019 to 2022, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read STRO current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 7.9% | $32.02 Million | $406.94 Million | ▼ -12.3 pp |
| 2021 | 20.1% | $68.78 Million | $341.41 Million | ▲ +10.2 pp |
| 2019 | 10.0% | $15.61 Million | $156.37 Million | — |